Vetaş

What Vetaş does

Vetaş is a Turkish veterinary pharmaceutical brand that has operated under DEVA Holding since its founding in 1973. The company manufactures and distributes veterinary health products across seven therapeutic areas — antibacterials, antiparasites, vitamins/minerals/aminoacids, hormones, aquaculture products, disinfectants, and other veterinary medications — serving veterinarians and animal breeders in Turkey. Its portfolio includes legacy brands such as Vetimisin (a penicillin product that has held market leadership since launch in 1973), the Gentavet gentamicin line, Fiproteam fipronil-based antiparasitics, and aquaculture products such as Diaqua, alongside more recent entries into the companion animal (pet) category.

Products are produced at DEVA Holding's manufacturing infrastructure, which includes four facilities in Çerkezköy and Kartepe equipped with GMP certifications and, in the case of Kartepe, US FDA approval. The Çerkezköy-I plant produced 183 million boxes in 2025, supported by the Çerkezköy-IV Logistics Center with 43,500 pallet capacity — described as one of Turkey's largest pharmaceutical logistics centers. R&D is conducted through the DEVARGE center, a multidisciplinary operation with 400+ researchers covering pharmaceutical development, API synthesis, biotechnology, biosimilar development, and analytical/CMC work.

Vetaş operates a sales-led, professional-channel go-to-market model, distributing directly to veterinarians and animal breeders through dedicated sales representatives and reseller networks. Marketing is anchored on the Vetakademi Kampüs scientific education program for veterinarians and Vademekum product catalogs. The brand is wholly consolidated within DEVA Holding (itself majority-owned since 2006 by EastPharma Limited, a GEM Global affiliate), following Vetaş's 2016 merger into the parent.

Name

Vetaş

Legal name

Vetaş

Website

https://vetas.com.tr

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

11–50 employees

Short description

Vetaş is a Turkish veterinary pharmaceutical brand operating under DEVA Holding since 1973, manufacturing and distributing animal health products across seven therapeutic areas to veterinarians and animal breeders in Turkey.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

akta.pro secondary industries

Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH), Animal Health OTC Retail (Parasite Control, Basic Care) (HLAMAIAJ)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Veterinary antibacterials
• Livestock medications
• Companion animal drugs

Headquarters

HQ city

Istanbul

HQ country

Türkiye

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Pharmaceutical Products: Vetaş generates revenue through the sale of veterinary health products across 7 therapeutic areas including antibacterials, antiparasites, vitamins/minerals/aminoacids, hormones, aquaculture products, disinfectants, and other veterinary medications. Products are sold to veterinarians and animal breeders.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Vetaş manufactures and markets veterinary pharmaceutical products across seven therapeutic areas (antibacterials, antiparasites, vitamins/minerals/aminoacids, hormones, aquaculture products, disinfectants, and other veterinary medications) for veterinarians and animal breeders in Turkey. Products are manufactured at DEVA Holding's GMP-certified and US FDA-approved facilities in Çerkezköy and Kartepe, and distributed through professional animal health channels. The portfolio includes legacy brands such as Vetimisin and Gentavet as well as newer categories such as pet companion animal products launched since 2023.

Product overview

Vetaş is a veterinary pharmaceutical company operating under DEVA Holding since 1973. The company offers a broad product portfolio across 7 therapeutic areas including Antibacterials, Antiparasites, Vitamins/Minerals/Aminoacids, Hormones, Aquaculture Products, Disinfectants, and Other Products. Key products include Vetimisin (penicillin market leader since 1973), Gentavet line (gentamicin-based antibiotics), Geosol (oxytetracycline products), Fiproteam (fipronil-based antiparasitics), and various hormone products like Vetaş Oksitosin and Vetaş Atropin. Products are manufactured at DEVA Holding's GMP-certified facilities in Çerkezköy and Kartepe, serving veterinarians and animal breeders across Turkey.

Differentiator

Problem solved

Functional benefit

Products and services

• Fourquinom %2,5 Enjeksiyonluk Süspansiyon

Quantifiable outcome

• Vetimisin has maintained penicillin market leadership since first day of launch in 1973
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators7 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Elanco Animal Health: Elanco is a major global animal health company with deep portfolios in livestock and companion animal pharmaceuticals. A broad incumbent competing with Vetaş across multiple therapeutic categories.
• MSD Animal Health (Merck): MSD Animal Health (Merck) is a leading global animal health division offering pharmaceuticals, vaccines, and health management solutions. Competes broadly with Vetaş in antibacterials, parasiticides, and vaccines in Turkey.
• Boehringer Ingelheim Animal Health: Boehringer Ingelheim's Animal Health division is one of the global top players in veterinary pharmaceuticals, vaccines, and therapeutics. A larger incumbent operating broadly across the same product categories as Vetaş in Turkey.

Direct peers

• Ceva Santé Animale: Ceva is a global veterinary pharmaceutical company headquartered in France, with strong positions in poultry, swine, ruminants, and companion animal therapeutics including vaccines and pharmaceuticals. Directly comparable to Vetaş's mixed livestock/companion animal focus.
• Virbac: Virbac is a France-based global veterinary pharmaceutical company with a broad portfolio across antibacterials, parasiticides, vaccines, and specialty therapeutics for companion and farm animals. It is one of the closest direct comparables to Vetaş in terms of portfolio breadth and channel model.
• Vetoquinol: Vetoquinol is an independent French veterinary pharmaceutical company focused on livestock and companion animal health products, with a portfolio spanning anti-infectives, parasiticides, and supportive therapies. Closely comparable to Vetaş in therapeutic area coverage and distribution approach.
• Phibro Animal Health: Phibro Animal Health is a US-based diversified animal health and mineral nutrition company serving livestock and aquaculture producers globally. Directly comparable to Vetaş in livestock-focused pharmaceutical portfolio, particularly in aquaculture.
• Zoetis: Zoetis is the world's largest pure-play animal health company, offering pharmaceuticals, vaccines, diagnostics and medicated feed additives across companion and livestock animals. It is the global benchmark Vetaş competes against in antibacterials, parasiticides, vaccines, and aquaculture products.
• Dechra Pharmaceuticals: Dechra is a UK-based specialty veterinary pharmaceuticals company focused on companion animal and livestock therapeutics, with strengths in endocrinology, dermatology, and anti-infectives. Comparable to Vetaş in therapeutic category focus and channel-to-veterinarian model.

Emerging players

• Alivira Animal Health: Alivira is an India-based veterinary pharmaceutical company with a broad portfolio across antibacterials, parasiticides, and nutritionals, with regional focus in South Asia, Middle East, and Africa. Comparable emerging-market peer with similar portfolio breadth and channel model to Vetaş.

Market position

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vetas

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vetaş